It took 13 years and nearly $3 billion to sequence the first single human genome, a proverbial lifetime and bank bailout away from the goal of a $1000 genome for an individual’s DNA sequence.
The Food and Drug Administration’s (FDA) approval of a clinical trial involving a human embryonic stem cell-based therapy is being hailed both as a triumph of science over politics, as well as heralding a much-needed financial shot in the arm for the nascent hESC biotech industry.
Lyophilization Services of New England, Inc. (LSNE) has provided CGMP contract manufacturing services since 1997.
A new discovery shows that cellular mechanisms used by the blind mole rat to survive the very low oxygen environment of its subterranean niche are the same as those that tumors use to thrive deep in our tissues.
High levels of a protein linked to the way pain signals are sent to the brain led to a decrease in abdominal pain in a recent study in mice.
Every few months, the Food and Drug Administration goes into fire-brigade mode, rushing to get control over another safety crisis.
Alloksys Life Sciences BV, CEVEC Pharmaceuticals GmbH, and PharmaCell BV announced the start of Theraptech, a 2.4 million Euro therapeutic protein development program subsidized under the European Trans Bio Program.
UCLA researchers report that a naturally occurring compound found in broccoli and other cruciferous vegetables may help protect against respiratory inflammation that causes conditions like asthma.
UCSF researchers have found that examining levels of antiretroviral drugs in hair samples taken from HIV patients on therapy strongly predicts treatment success.
The helpless behavior that is commonly linked to depression and post-traumatic stress disorder (PTSD) is preceded by stress-related losses of synapses in the brain’s hippocampal region.
The latest clinical trials, updates, orphan drug designations, and FDA approvals from pharma and biotech companies.
At Malmö University Hospital, Lund University in Sweden, large screening tests results in a continuous identification of children that are subject to a very high risk of developing type 1 diabetes.
A new approach to fighting bacterial infections could help prevent bacteria from developing antibiotic resistance and help kill those that have already become resistant.
Researchers have identified a gene that modifies the severity of lung disease in people with cystic fibrosis.
An immune system response that is critical to the first stages of fighting off viruses and harmful bacteria comes from an entirely different direction than most scientists had thought.